Drug intelligence / Profile preview

lactoferrin + ferrous fumarate

Development stage: Unknown
Lead developer: All G
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Oral

Overview

A combination drug consisting of lactoferrin and ferrous fumarate used primarily for the treatment of iron deficiency anemia, especially during pregnancy. Lactoferrin is an iron-binding glycoprotein that enhances iron absorption and has anti-inflammatory and antimicrobial properties. Ferrous fumarate provides the iron source. This combination has been shown to be more effective than either component alone in improving hemoglobin levels, serum iron, and other blood parameters while causing fewer gastrointestinal side effects than traditional iron supplements.

Beyond the preview

Go deeper on lactoferrin + ferrous fumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactoferrin + ferrous fumarate.

Explore the full profile